Cargando…
Improving End-User Trust in the Quality of Commercial Probiotic Products
In a rapidly growing global probiotic market, end-users have difficulty distinguishing between high quality and poor quality products. This ambiguity threatens the trust consumers and healthcare providers have in probiotic products. To address this problem, we recommend that companies undergo third-...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499161/ https://www.ncbi.nlm.nih.gov/pubmed/31105649 http://dx.doi.org/10.3389/fmicb.2019.00739 |
_version_ | 1783415751379517440 |
---|---|
author | Jackson, Scott A. Schoeni, Jean L. Vegge, Christina Pane, Marco Stahl, Buffy Bradley, Michael Goldman, Virginia S. Burguière, Pierre Atwater, John B. Sanders, Mary Ellen |
author_facet | Jackson, Scott A. Schoeni, Jean L. Vegge, Christina Pane, Marco Stahl, Buffy Bradley, Michael Goldman, Virginia S. Burguière, Pierre Atwater, John B. Sanders, Mary Ellen |
author_sort | Jackson, Scott A. |
collection | PubMed |
description | In a rapidly growing global probiotic market, end-users have difficulty distinguishing between high quality and poor quality products. This ambiguity threatens the trust consumers and healthcare providers have in probiotic products. To address this problem, we recommend that companies undergo third-party evaluations to certify probiotic quality and label accuracy. In order to communicate about product quality to end-users, indication of certification on product labels is helpful, although not all manufacturers choose to use this approach. Herein we discuss: third-party certification, the process of setting standards for identity, purity, and quantification of probiotics; some emerging methodologies useful for quality assessment; and some technical challenges unique to managing quality of live microbial products. This review provides insights of an Expert Panel engaged in this process and aims to update the reader on relevant current scientific methodologies. Establishing validated methodologies for all aspects of quality assessment is an essential component of this process and can be facilitated by established organizations, such as United States Pharmacopeia. Emerging methodologies including whole genome sequencing and flow cytometry are poised to play important roles in these processes. |
format | Online Article Text |
id | pubmed-6499161 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64991612019-05-17 Improving End-User Trust in the Quality of Commercial Probiotic Products Jackson, Scott A. Schoeni, Jean L. Vegge, Christina Pane, Marco Stahl, Buffy Bradley, Michael Goldman, Virginia S. Burguière, Pierre Atwater, John B. Sanders, Mary Ellen Front Microbiol Microbiology In a rapidly growing global probiotic market, end-users have difficulty distinguishing between high quality and poor quality products. This ambiguity threatens the trust consumers and healthcare providers have in probiotic products. To address this problem, we recommend that companies undergo third-party evaluations to certify probiotic quality and label accuracy. In order to communicate about product quality to end-users, indication of certification on product labels is helpful, although not all manufacturers choose to use this approach. Herein we discuss: third-party certification, the process of setting standards for identity, purity, and quantification of probiotics; some emerging methodologies useful for quality assessment; and some technical challenges unique to managing quality of live microbial products. This review provides insights of an Expert Panel engaged in this process and aims to update the reader on relevant current scientific methodologies. Establishing validated methodologies for all aspects of quality assessment is an essential component of this process and can be facilitated by established organizations, such as United States Pharmacopeia. Emerging methodologies including whole genome sequencing and flow cytometry are poised to play important roles in these processes. Frontiers Media S.A. 2019-04-17 /pmc/articles/PMC6499161/ /pubmed/31105649 http://dx.doi.org/10.3389/fmicb.2019.00739 Text en Copyright © 2019 Jackson, Schoeni, Vegge, Pane, Stahl, Bradley, Goldman, Burguière, Atwater and Sanders. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Jackson, Scott A. Schoeni, Jean L. Vegge, Christina Pane, Marco Stahl, Buffy Bradley, Michael Goldman, Virginia S. Burguière, Pierre Atwater, John B. Sanders, Mary Ellen Improving End-User Trust in the Quality of Commercial Probiotic Products |
title | Improving End-User Trust in the Quality of Commercial Probiotic Products |
title_full | Improving End-User Trust in the Quality of Commercial Probiotic Products |
title_fullStr | Improving End-User Trust in the Quality of Commercial Probiotic Products |
title_full_unstemmed | Improving End-User Trust in the Quality of Commercial Probiotic Products |
title_short | Improving End-User Trust in the Quality of Commercial Probiotic Products |
title_sort | improving end-user trust in the quality of commercial probiotic products |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499161/ https://www.ncbi.nlm.nih.gov/pubmed/31105649 http://dx.doi.org/10.3389/fmicb.2019.00739 |
work_keys_str_mv | AT jacksonscotta improvingendusertrustinthequalityofcommercialprobioticproducts AT schoenijeanl improvingendusertrustinthequalityofcommercialprobioticproducts AT veggechristina improvingendusertrustinthequalityofcommercialprobioticproducts AT panemarco improvingendusertrustinthequalityofcommercialprobioticproducts AT stahlbuffy improvingendusertrustinthequalityofcommercialprobioticproducts AT bradleymichael improvingendusertrustinthequalityofcommercialprobioticproducts AT goldmanvirginias improvingendusertrustinthequalityofcommercialprobioticproducts AT burguierepierre improvingendusertrustinthequalityofcommercialprobioticproducts AT atwaterjohnb improvingendusertrustinthequalityofcommercialprobioticproducts AT sandersmaryellen improvingendusertrustinthequalityofcommercialprobioticproducts |